// App-Quantinova.ai

P232 : Effectiveness of adalimumab biosimilar switching: real world data from a London rheumatology centre

Researchers

Presenter

  • Shivanee Vigneswaran

Principal Investigators

  • Megan Galloway

  • Samuel Hanlon

  • Aoife Tynan

  • Animesh Singh

Medical Centers

  • Academic Department of Rheumatology, King's College London, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab biosimilar

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved